EN
HI
Summary
As of 11 Oct, 2026, Glenmark Pharmaceuticals stock price is ₹2293. During the trading session, the stock has moved between an intraday low of ₹2203.00 and an intraday high of ₹2293.00. Over the last 52 weeks, Glenmark Pharmaceuticals has traded between ₹1792.60 and ₹2537.60.
The stock has recorded a trading volume of 4,14,339 shares,. Its Average Traded Price (ATP) is ₹2256.98, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2293.00.
Glenmark Pharmaceuticals has an upper circuit limit of ₹2522.30 and a lower circuit limit of ₹2063.70. The total value traded stands at ₹93.52 CR, and the delivery percentage for the day is 60.79%.
The stock is currently traded with a market lot size of 1. Glenmark Pharmaceuticals also offers a dividend yield of 0.11%.
Glenmark Pharmaceuticals Share Price Chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
4.14 L
Market Cap
64714.12 CR
LTQ@LTP
1@2293.00
ATP
2256.98
Var Margin
15.34 %
Circuit Range
2063.7-2522.3
Delivery %
60.79 %
Value
93.52 CR
ASM/GSM
No
Market Lot
1
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
35.97
P/B Ratio
5.9
Div. Yield
0.11
Sector P/E
41.33
Sector P/B
3.47
Sec. Div. Yield
0.53
Glenmark Pharmaceuticals Resistance and Support
Pivot 2219.13
Resistance
First Resistance
2257.06
Second Resistance
2321.93
Third Resistance
2359.86
Support
First Support
2154.26
Second Support
2116.33
Third Support
2051.46
Glenmark Pharmaceuticals Futures & Options
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
27OCT26
2303.00
95.70 (4.34%)
23NOV26
2310.60
93.20 (4.20%)
29DEC26
2322.00
0.00 (0.00%)
GLENMARK|27OCT26 CE 2280.00
65.70
37.6 (133.81%)
GLENMARK|27OCT26 PE 2300.00
54
-67.1 (-55.41%)
Glenmark Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 2207 | 2293 | 4.60% | 2293 | 2203 |
| Thu Oct 08 2026 | 2280 | 2192.19 | -3.95% | 2284 | 2181.19 |
| Wed Oct 07 2026 | 2314.89 | 2282.3 | -1.24% | 2326.8 | 2274.39 |
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark launched Adapalene Gel USP 0.1% OTC in new pump packs in the US. The target market for this product (Differin Gel 0.1%) has annual sales of approximately $45.8 million. The launch strengthens the company's US dermatology portfolio.
Oct 06 2026 08:39:28
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals announced it received an Establishment Inspection Report (EIR) from the U.S. FDA for its Goa formulations manufacturing facility, with a Voluntary Action Indicated (VAI) status. This classification indicates regulatory compliance following an inspection from June 22 to June 30, 2026.
Sep 23 2026 08:46:29
Read More
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Dr. Reddy's Laboratories Ltd.
1197.00
17.00 (1.44%)
Aurobindo Pharma Ltd.
1693.00
48.00 (2.92%)
Manipal Health Enterprises Ltd.
701.30
17.25 (2.52%)
Lupin Ltd.
1956.50
19.60 (1.01%)
Max Healthcare Institute Ltd.
883.80
10.40 (1.19%)
Alkem Laboratories Ltd.
5279.00
29.50 (0.56%)
Aster DM Quality Care Ltd.
699.85
22.70 (3.35%)
Fortis Healthcare Ltd.
786.25
23.25 (3.05%)
Biocon Ltd.
349.40
-0.60 (0.17%)
Abbott India Ltd.
26000.00
420.00 (1.64%)
Glenmark Pharmaceuticals FAQs
The Buying Price of Glenmark Pharmaceuticals share is 2293 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glenmark Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glenmark Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glenmark Pharmaceuticals shares is 35.97. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glenmark Pharmaceuticals shares is 5.9. Useful to assess the stock's value relative to its book value.
To assess Glenmark Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.33 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glenmark Pharmaceuticals is 64714.12 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glenmark Pharmaceuticals share price is 2537.60 & 1792.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glenmark Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLENMARK
